RNA biomarker-based diagnostics
expressTec is a biotech startup company founded by two women and a spin-off from the University of Algarve. Their vision is to provide patients with easy access to accurate personalized cancer therapy. To achieve this, they are developing RNA-based approaches to revolutionize clinical testing by accurately and efficiently selecting cancer patients for targeted therapies. Their innovative approach will help to optimize treatment outcomes, reduce side effects, and ultimately improve the quality of life for cancer patients. Their mission is to transform cancer care through cutting-edge technology focused on patient-centred solutions.
- Women TechEU 2023, Women in Tech Algarve – 1st place Pitch Competition
- Altice International Innovation Award – Startup winner
- SantanderX University Portugal 2023 – winner